264 related articles for article (PubMed ID: 17158518)
1. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450-mediated biotransformation (a corrigendum report on Duarte et al. (2005) Mutagenesis 20, 93-100).
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2007 Jan; 22(1):75-81. PubMed ID: 17158518
[TBL] [Abstract][Full Text] [Related]
2. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
[TBL] [Abstract][Full Text] [Related]
3. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
[TBL] [Abstract][Full Text] [Related]
4. Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines.
Duarte MP; Palma BB; Laires A; Oliveira JS; Rueff J; Kranendonk M
Mutagenesis; 2005 May; 20(3):199-208. PubMed ID: 15843388
[TBL] [Abstract][Full Text] [Related]
5. Metabolic activation of N-alkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase.
Kushida H; Fujita K; Suzuki A; Yamada M; Endo T; Nohmi T; Kamataki T
Carcinogenesis; 2000 Jun; 21(6):1227-32. PubMed ID: 10837014
[TBL] [Abstract][Full Text] [Related]
6. Competitive interactions between cytochromes P450 2A6 and 2E1 for NADPH-cytochrome P450 oxidoreductase in the microsomal membranes produced by a baculovirus expression system.
Tan Y; Patten CJ; Smith T; Yang CS
Arch Biochem Biophys; 1997 Jun; 342(1):82-91. PubMed ID: 9185616
[TBL] [Abstract][Full Text] [Related]
7. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
Fujita K; Kamataki T
Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
[TBL] [Abstract][Full Text] [Related]
8. Development of a Salmonella tester strain sensitive to promutagenic N-nitrosamines: expression of recombinant CYP2A6 and human NADPH-cytochrome P450 reductase in S. typhimurium YG7108.
Kushida H; Fujita K; Suzuki A; Yamada M; Nohmi T; Kamataki T
Mutat Res; 2000 Nov; 471(1-2):135-43. PubMed ID: 11080669
[TBL] [Abstract][Full Text] [Related]
9. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome b(5) coexpression increases the CYP2E1-dependent mutagenicity of dialkylnitrosamines in methyltransferase-deficient strains of Salmonella typhimurium.
Cooper MT; Porter TD
Mutat Res; 2001 Dec; 484(1-2):61-8. PubMed ID: 11733072
[TBL] [Abstract][Full Text] [Related]
11. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
Patten CJ; Koch P
Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
[TBL] [Abstract][Full Text] [Related]
12. Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificity in the gpt gene of AS52 cells.
Tiano HF; Wang RL; Hosokawa M; Crespi C; Tindall KR; Langenbach R
Carcinogenesis; 1994 Dec; 15(12):2859-66. PubMed ID: 8001247
[TBL] [Abstract][Full Text] [Related]
13. Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes.
Zhang H; Gao N; Liu T; Fang Y; Qi B; Wen Q; Zhou J; Jia L; Qiao H
PLoS One; 2015; 10(6):e0128547. PubMed ID: 26046844
[TBL] [Abstract][Full Text] [Related]
14. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
[TBL] [Abstract][Full Text] [Related]
15. Comparative metabolism of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol by rat cytochrome P450 2A3 and human cytochrome P450 2A13.
Jalas JR; Ding X; Murphy SE
Drug Metab Dispos; 2003 Oct; 31(10):1199-202. PubMed ID: 12975327
[TBL] [Abstract][Full Text] [Related]
16. Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Tiano HF; Hosokawa M; Chulada PC; Smith PB; Wang RL; Gonzalez FJ; Crespi CL; Langenbach R
Carcinogenesis; 1993 Jul; 14(7):1421-7. PubMed ID: 8330360
[TBL] [Abstract][Full Text] [Related]
17. Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: the effect of the expression of cytochrome b(5) with recombinant P450 enzymes.
Emoto C; Iwasaki K
Xenobiotica; 2007 Sep; 37(9):986-99. PubMed ID: 17896325
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytochrome P450 2A6 in Escherichia coli: purification, spectral and catalytic characterization, and preparation of polyclonal antibodies.
Soucek P
Arch Biochem Biophys; 1999 Oct; 370(2):190-200. PubMed ID: 10510277
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytochrome P450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma.
Tsukino H; Kuroda Y; Qiu D; Nakao H; Imai H; Katoh T
Int J Cancer; 2002 Aug; 100(4):425-8. PubMed ID: 12115524
[TBL] [Abstract][Full Text] [Related]
20. Role of human cytochrome P450 (CYP) in the metabolic activation of nitrosamine derivatives: application of genetically engineered Salmonella expressing human CYP.
Kamataki T; Fujita K; Nakayama K; Yamazaki Y; Miyamoto M; Ariyoshi N
Drug Metab Rev; 2002 Aug; 34(3):667-76. PubMed ID: 12214673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]